Trial Profile
A phase I/ IIa study of tolerogenic vaccine for kidney transplantation
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 19 May 2017
Price :
$35
*
At a glance
- Drugs Tolerogenic vaccine-Idogen (Primary)
- Indications Haemophilia A
- Focus Adverse reactions; Therapeutic Use
- 19 May 2017 New trial record
- 11 May 2017 According to an Idogen media release, the company is being conducted with the intention of initiating a Phase I/IIa study within kidney transplantation in 2019.